Literature DB >> 25550445

Alanyl-glutamine improves pancreatic β-cell function following ex vivo inflammatory challenge.

Vinicius Fernandes Cruzat1, Kevin Noel Keane2, Anita Lavarda Scheinpflug2, Robson Cordeiro2, Mario J Soares2, Philip Newsholme2.   

Abstract

Obesity-associated diabetes and concomitant inflammation may compromise pancreatic β-cell integrity and function. l-glutamine and l-alanine are potent insulin secretagogues, with antioxidant and cytoprotective properties. Herein, we studied whether the dipeptide l-alanyl-l-glutamine (Ala-Gln) could exert protective effects via sirtuin 1/HUR (SIRT1/HUR) signalling in β-cells, against detrimental responses following ex vivo stimulation with inflammatory mediators derived from macrophages (IMMs). The macrophages were derived from blood obtained from obese subjects. Macrophages were exposed (or not) to lipopolysaccharide (LPS) to generate a pro-inflammatory cytokine cocktail. The cytokine profile was determined following analysis by flow cytometry. Insulin-secreting BRIN-BD11 β-cells were exposed to IMMs and then cultured with or without Ala-Gln for 24 h. Chronic insulin secretion, the l-glutamine-glutathione (GSH) axis, and the level of insulin receptor β (IR-β), heat shock protein 70 (HSP70), SIRT1/HUR, CCAAT-enhancer-binding protein homologous protein (CHOP) and cytochrome c oxidase IV (COX IV) were evaluated. Concentrations of cytokines, including interleukin 1β (IL1β), IL6, IL10 and tumour necrosis factor alpha (TNFα) in the IMMs, were higher following exposure to LPS. Subsequently, when β-cells were exposed to IMMs, chronic insulin secretion, and IR-β and COX IV levels were decreased, but these effects were partially or fully attenuated by the addition of Ala-Gln. The glutamine-GSH axis and HSP70 levels, which were compromised by IMMs, were also restored by Ala-Gln, possibly due to protection of SIRT1/HUR levels, and a reduction of CHOP expression. Using an ex vivo inflammatory approach, we have demonstrated Ala-Gln-dependent β-cell protection mediated by coordinated effects on the glutamine-GSH axis, and the HSP pathway, maintenance of mitochondrial metabolism and stimulus-secretion coupling essential for insulin release.
© 2015 Society for Endocrinology.

Entities:  

Keywords:  GSH; HSP; alanine; diabetes; glutamine; sirtuin 1

Mesh:

Substances:

Year:  2014        PMID: 25550445     DOI: 10.1530/JOE-14-0677

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

1.  Early initiation of low-level parenteral dextrose induces an accelerated diabetic phenotype in septic C57BL/6J mice.

Authors:  Srikanth Singamsetty; Faraaz Ali Shah; Lanping Guo; Yoshio Watanabe; Sherie McDonald; Rohit Sharma; Yingze Zhang; Laura C Alonso; Christopher P O'Donnell; Bryan J McVerry
Journal:  Appl Physiol Nutr Metab       Date:  2015-09-09       Impact factor: 2.665

2.  Alanyl-Glutamine Protects against Lipopolysaccharide-Induced Liver Injury in Mice via Alleviating Oxidative Stress, Inhibiting Inflammation, and Regulating Autophagy.

Authors:  Jiaji Hu; Hanglu Ying; Yigang Zheng; Huabin Ma; Long Li; Yufen Zhao
Journal:  Antioxidants (Basel)       Date:  2022-05-27

3.  Oral supplementations with L-glutamine or L-alanyl-L-glutamine do not change metabolic alterations induced by long-term high-fat diet in the B6.129F2/J mouse model of insulin resistance.

Authors:  Patricia Martins Bock; Mauricio Krause; Helena Trevisan Schroeder; Gabriela Fernandes Hahn; Hilton Kenji Takahashi; Cinthia Maria Schöler; Graziella Nicoletti; Luiz Domingos Zavarize Neto; Maria Inês Lavina Rodrigues; Maciel Alencar Bruxel; Paulo Ivo Homem de Bittencourt
Journal:  Mol Cell Biochem       Date:  2015-11-03       Impact factor: 3.396

4.  Prospective evaluation of glutamine and phospholipids levels in first degree relatives of patients with Type 1 Diabetes from a multiethnic population.

Authors:  D B Araujo de Pina Cabral; J R Dantas; H Skärstrand; B Barone; F Carvalho; R Tortora; A Milech; F Vaziri-Sani; J E P Oliveira; L Zajdenverg; M Rodacki
Journal:  Diabetol Metab Syndr       Date:  2015-06-10       Impact factor: 3.320

5.  Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes.

Authors:  Wenkai Ren; Yaoyao Xia; Siyuan Chen; Guoyao Wu; Fuller W Bazer; Beiyan Zhou; Bie Tan; Guoqiang Zhu; Jinping Deng; Yulong Yin
Journal:  Adv Nutr       Date:  2019-03-01       Impact factor: 8.701

6.  Oral L-glutamine rescues fructose-induced poor fetal outcome by preventing placental triglyceride and uric acid accumulation in Wistar rats.

Authors:  Kehinde Samuel Olaniyi; Isaiah Woru Sabinari; Lawrence Aderemi Olatunji
Journal:  Heliyon       Date:  2020-12-28

Review 7.  Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and β-Cell Dysfunction.

Authors:  Kevin Noel Keane; Vinicius Fernandes Cruzat; Rodrigo Carlessi; Paulo Ivo Homem de Bittencourt; Philip Newsholme
Journal:  Oxid Med Cell Longev       Date:  2015-07-14       Impact factor: 6.543

Review 8.  Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation.

Authors:  Vinicius Cruzat; Marcelo Macedo Rogero; Kevin Noel Keane; Rui Curi; Philip Newsholme
Journal:  Nutrients       Date:  2018-10-23       Impact factor: 5.717

9.  Cellular Metabolic Profiling of CrFK Cells Infected with Feline Infectious Peritonitis Virus Using Phenotype Microarrays.

Authors:  Shing Wei Ng; Gayathri Thevi Selvarajah; Yoke Kqueen Cheah; Farina Mustaffa Kamal; Abdul Rahman Omar
Journal:  Pathogens       Date:  2020-05-25

Review 10.  Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach.

Authors:  Didier Ducloux; Cécile Courivaud
Journal:  J Pers Med       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.